These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 25559329)
1. Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance. Anstee QM; Liu YL; Day CP; Reeves HL J Hepatol; 2015 Apr; 62(4):982-3. PubMed ID: 25559329 [No Abstract] [Full Text] [Related]
2. HCC and liver disease risks in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance. Krawczyk M; Stokes CS; Romeo S; Lammert F J Hepatol; 2015 Apr; 62(4):980-1. PubMed ID: 25559327 [No Abstract] [Full Text] [Related]
3. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. Liu YL; Patman GL; Leathart JB; Piguet AC; Burt AD; Dufour JF; Day CP; Daly AK; Reeves HL; Anstee QM J Hepatol; 2014 Jul; 61(1):75-81. PubMed ID: 24607626 [TBL] [Abstract][Full Text] [Related]
4. PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma. Valenti L; Motta BM; Soardo G; Iavarone M; Donati B; Sangiovanni A; Carnelutti A; Dongiovanni P; Rametta R; Bertelli C; Facchetti F; Colombo M; Fargion S; Fracanzani AL PLoS One; 2013; 8(10):e75982. PubMed ID: 24155878 [TBL] [Abstract][Full Text] [Related]
5. Association of PNPLA3 Polymorphism with Hepatocellular Carcinoma Development and Prognosis in Viral and Non-Viral Chronic Liver Diseases. Khlaiphuengsin A; Kiatbumrung R; Payungporn S; Pinjaroen N; Tangkijvanich P Asian Pac J Cancer Prev; 2015; 16(18):8377-82. PubMed ID: 26745088 [TBL] [Abstract][Full Text] [Related]
6. The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus. Ueyama M; Nishida N; Korenaga M; Korenaga K; Kumagai E; Yanai H; Adachi H; Katsuyama H; Moriyama S; Hamasaki H; Sako A; Sugiyama M; Aoki Y; Imamura M; Murata K; Masaki N; Kawaguchi T; Torimura T; Hyogo H; Aikata H; Ito K; Sumida Y; Kanazawa A; Watada H; Okamoto K; Honda K; Kon K; Kanto T; Mizokami M; Watanabe S J Gastroenterol; 2016 Apr; 51(4):370-9. PubMed ID: 26337813 [TBL] [Abstract][Full Text] [Related]
7. Is Hepatocellular Cancer the Same Disease in Alcoholic and Nonalcoholic Fatty Liver Diseases? Goossens N; Hoshida Y Gastroenterology; 2016 Jun; 150(8):1710-7. PubMed ID: 26784140 [No Abstract] [Full Text] [Related]
18. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis. Chen LZ; Xin YN; Geng N; Jiang M; Zhang DD; Xuan SY World J Gastroenterol; 2015 Jan; 21(3):794-802. PubMed ID: 25624712 [TBL] [Abstract][Full Text] [Related]
19. The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long-term clinical outcome in chronic hepatitis B patients. Brouwer WP; van der Meer AJ; Boonstra A; Pas SD; de Knegt RJ; de Man RA; Hansen BE; ten Kate FJ; Janssen HL Liver Int; 2015 Feb; 35(2):438-47. PubMed ID: 25284145 [TBL] [Abstract][Full Text] [Related]
20. I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease. Park JH; Cho B; Kwon H; Prilutsky D; Yun JM; Choi HC; Hwang KB; Lee IH; Kim JI; Kong SW Liver Int; 2015 Dec; 35(12):2537-46. PubMed ID: 26148225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]